CapsoVision (CV) Net Margin (2024 - 2026)
CapsoVision (CV) posted Net Margin of 188.72% for Q4 2025, up 15.71% sequentially from 223.88% in Q3 2025, and down 5433.0% YoY from 3.54% in Q4 2024.
CapsoVision (CV) Net Margin (2024 - 2026) Analysis & Trends
CapsoVision has reported Net Margin for 2 years, with the latest figure at 188.72% in Q4 2025.
- Quarterly Net Margin fell 5433.0% year-over-year to 188.72% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 172.81% (changed N/A YoY) and the FY2025 annual result came in at 186.77%, down 1751.0% from the prior year.
- Net Margin rose to 188.72% in Q4 2025 per CV's latest filing, from 223.88% in the prior quarter.
- Over five years, Net Margin peaked at 134.39% in Q4 2024 and troughed at 223.88% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 13.47% |
| 10 | CapsoVision | 295.63 Mn | 286.55 Mn | 1.87 Mn | -205.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -205.35% |
| Dec 31, 2025 | -188.72% |
| Sep 30, 2025 | -223.88% |
| Jun 30, 2025 | -139.52% |
| Dec 31, 2024 | -134.39% |
| Sep 30, 2024 | -195.35% |
| Jun 30, 2024 | -185.23% |